Dr Nizam on Enfortumab Vedotin After Maintenance Avelumab in Urothelial Cancer
Amanda Nizam, MD, discusses findings from the UNITE study of enfortumab vedotin after maintenance avelumab in patients with advanced urothelial carcinoma.
Source: onclive.com